On the occasion of the World Health Assembly, the hybrid event, “Accelerating innovations and access to #bettermeds4kids: a spotlight on medicines for children” convened by the Drugs for Neglected Diseases Initiative (DNDi), the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), and the Medicines Patent Pool (MPP) on behalf of the Global Accelerator for Paediatric Formulations (GAP-f) was held in Geneva. This event brought the experience from Member States, key stakeholders, and existing mechanisms that are effectively contributing to addressing paediatric medicine innovation and access challenges, aiming to contribute to mobilizing leadership around debates on clinical trials in forgotten populations and maternal, newborn and child health.

 

The objective of the session was to serve as the basis for continued advocacy by the Global Accelerator for Paediatric Formulations (GAP-f) WHO network, strengthening high-level political attention on innovation and access to adapted paediatric medicines, reviving the 2016 WHA resolution 69.20 on “Promoting innovation and access to quality, safe, efficacious and affordable medicines for children” towards inclusion in the agenda of a future WHA. 

 

More about the Global Accelerator for Paediatric Formulations (GAP-f).